Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy - PubMed

Affiliations

• PMID: 11793372
• DOI: 10.1002/path.1029

Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy

Bernard Burke et al. J Pathol. 2002 Feb.

Abstract

Large numbers of monocytes extravasate from the blood into human tumours, where they differentiate into macrophages. In both breast and prostate carcinomas, these cells accumulate in areas of low oxygen tension (hypoxia), where they respond to hypoxia with the up-regulation of one or more hypoxia-inducible factors (HIFs). These then accumulate in the nucleus and bind to short DNA sequences called hypoxia-response elements (HREs) near or in such oxygen-sensitive genes as that encoding the pro-angiogenic factor vascular endothelial growth factor (VEGF). This stimulates gene expression and could explain why, in part, macrophages express abundant VEGF only in avascular, hypoxic areas of breast carcinomas. It also suggests that macrophages could be used to deliver HRE-regulated therapeutic genes specifically to hypoxic tumour areas. A recent study suggested that hypoxic macrophages accumulate HIF-2 rather than HIF-1, prompting the search for HRE constructs that optimally bind HIF-2 for use in macrophage-based gene therapy protocols. However, the present study shows that human macrophages accumulate higher levels of HIF-1 than HIF-2 when exposed to tumour-specific levels of hypoxia in vitro; that macrophages in human tumours express abundant HIF-1; and that expression from HRE-driven reporter constructs in the human macrophage-like cell line MonoMac 6 correlates more closely with HIF-1 than with HIF-2 up-regulation under hypoxia. Taken together, these findings suggest that HIF-1 may be the major hypoxia-inducible transcription factor in macrophages and that HIF-1-regulated constructs are likely to be effective in macrophage delivery of hypoxia-regulated gene therapy to human tumours.

Similar articles

• Monocyte-derived macrophages matured under prolonged hypoxia transcriptionally up-regulate HIF-1α mRNA.

  Staples KJ, Sotoodehnejadnematalahi F, Pearson H, Frankenberger M, Francescut L, Ziegler-Heitbrock L, Burke B. Staples KJ, et al. Immunobiology. 2011 Jul;216(7):832-9. doi: 10.1016/j.imbio.2010.12.005. Epub 2010 Dec 22. Immunobiology. 2011. PMID: 21281980

• Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells.

  Post DE, Van Meir EG. Post DE, et al. Gene Ther. 2001 Dec;8(23):1801-7. doi: 10.1038/sj.gt.3301605. Gene Ther. 2001. PMID: 11803400

• Stabilization of hypoxia-inducible factor-1alpha is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells.

  Kim HH, Lee SE, Chung WJ, Choi Y, Kwack K, Kim SW, Kim MS, Park H, Lee ZH. Kim HH, et al. Cytokine. 2002 Jan 7;17(1):14-27. doi: 10.1006/cyto.2001.0985. Cytokine. 2002. PMID: 11886167

• Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration.

  Bosco MC, Puppo M, Blengio F, Fraone T, Cappello P, Giovarelli M, Varesio L. Bosco MC, et al. Immunobiology. 2008;213(9-10):733-49. doi: 10.1016/j.imbio.2008.07.031. Epub 2008 Sep 21. Immunobiology. 2008. PMID: 18926289 Review.

• Hypoxia inducible factor pathways as targets for functional foods.

  Losso JN, Bawadi HA. Losso JN, et al. J Agric Food Chem. 2005 May 18;53(10):3751-68. doi: 10.1021/jf0479719. J Agric Food Chem. 2005. PMID: 15884793 Review.

Cited by

• Peripheral nerve injury induces persistent vascular dysfunction and endoneurial hypoxia, contributing to the genesis of neuropathic pain.

  Lim TK, Shi XQ, Johnson JM, Rone MB, Antel JP, David S, Zhang J. Lim TK, et al. J Neurosci. 2015 Feb 25;35(8):3346-59. doi: 10.1523/JNEUROSCI.4040-14.2015. J Neurosci. 2015. PMID: 25716835 Free PMC article.

• HIF-1alpha is essential for myeloid cell-mediated inflammation.

  Cramer T, Yamanishi Y, Clausen BE, Förster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson RS. Cramer T, et al. Cell. 2003 Mar 7;112(5):645-57. doi: 10.1016/s0092-8674(03)00154-5. Cell. 2003. PMID: 12628185 Free PMC article.

• Tumour Microenvironment: Overview with an Emphasis on the Colorectal Liver Metastasis Pathway.

  Giakoustidis A, Mudan S, Hagemann T. Giakoustidis A, et al. Cancer Microenviron. 2015 Dec;8(3):177-86. doi: 10.1007/s12307-014-0155-5. Epub 2014 Oct 3. Cancer Microenviron. 2015. PMID: 25277516 Free PMC article.

• Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET.

  Huang Y, Fan J, Li Y, Fu S, Chen Y, Wu J. Huang Y, et al. Front Oncol. 2021 Sep 7;11:731503. doi: 10.3389/fonc.2021.731503. eCollection 2021. Front Oncol. 2021. PMID: 34557414 Free PMC article. Review.

• Immunotherapy Targeting Tumor-Associated Macrophages.

  Liu Y, Wang R. Liu Y, et al. Front Med (Lausanne). 2020 Nov 5;7:583708. doi: 10.3389/fmed.2020.583708. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33251232 Free PMC article. Review.

Publication types

MeSH terms

Substances